BusinessVeritas and Cannevert Complete Prestudy Visit of the Puerto Rico Clinical Trial FacilityBy Nasdaq OMXDec 29, 2017, 8:05 AM UTC
BusinessVeritas Pharma Subsidiary Receives Health Canada Dealer LicenceBy Nasdaq OMXDec 28, 2017, 8:05 AM UTC
BusinessVeritas Hires Medical Director to Advise Physicians & Regulators on the Application of Cannevert’s Experimental Results with Cannabis to Clinical Practice & Public PolicyBy Nasdaq OMXDec 8, 2017, 8:05 AM UTC
BusinessUS Patent Office Acknowledges Provisional Patent Application for Use of Specific Cannabis Strain to Enhance Opioid Analgesia Filed by Veritas’ Research Arm CannevertBy Nasdaq OMXNov 28, 2017, 8:05 AM UTC
